Fundies. English
SOPHIRIS BIO INC.
EDGAR30 filing records in this dataset, filed from 2013-02-15 to 2019-11-13. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 4.25 million iso4217-usd Source
Exact value
4251000 iso4217-usd
- Long-term debt including current maturities
- 5.95 million iso4217-usd Source
Exact value
5950000 iso4217-usd
- Shares outstanding
- 33.6 million xbrli-shares Source
Exact value
33572140 xbrli-shares
Reported share-count change
11.49% · 3.46 million xbrli-shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2019-11-13.
Financial data available through: 2018-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- operating income: No compatible figures in this window
- Net income: 6 of 11 periods available· newest 2018-12-31
- Operating cash flow: 6 of 11 periods available· newest 2018-12-31
- Capital expenditure: 4 of 11 periods available· newest 2018-12-31
- Total assets: 5 of 11 periods available· newest 2018-12-31
- Total liabilities: 5 of 11 periods available· newest 2018-12-31
- Current assets: 5 of 11 periods available· newest 2018-12-31
- Current liabilities: 5 of 11 periods available· newest 2018-12-31
- Cash and cash equivalents: 7 of 11 periods available· newest 2018-12-31
- Long-term debt including current maturities: 3 of 11 periods available· newest 2018-12-31
- Shares outstanding: 5 of 11 periods available· newest 2018-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+iso4217-usd 1.85 millionPrior period
−iso4217-usd 8.63 million
–
Current period
−iso4217-usd 6.78 million
–
Exact inputs and evidence
-6778000 − -8628000 = 1850000 iso4217-usd
-8628000 iso4217-usd · 2017-01-01 – 2017-12-31
Inspect prior input Prior source-6778000 iso4217-usd · 2018-01-01 – 2018-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−iso4217-usd 3.49 millionPrior period
−iso4217-usd 9.97 million
–
Current period
−iso4217-usd 13.46 million
–
Exact inputs and evidence
-13457000 − -9968000 = -3489000 iso4217-usd
-9968000 iso4217-usd · 2017-01-01 – 2017-12-31
Inspect prior input Prior source-13457000 iso4217-usd · 2018-01-01 – 2018-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+33.3%Prior period
iso4217-usd 3,000
–
Current period
iso4217-usd 4,000
–
Exact inputs and evidence
4000 − 3000 = 1000 iso4217-usd
3000 iso4217-usd · 2017-01-01 – 2017-12-31
Inspect prior input Prior source4000 iso4217-usd · 2018-01-01 – 2018-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Values and sources
| Period | Series | Value(iso4217-usd) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2013 2013-01-01 – 2013-12-31 | −iso4217-usd 11.15 million Exact valueExact value: -11149000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | −iso4217-usd 13.21 million Exact valueExact value: -13206000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | iso4217-usd 3,000 Exact valueExact value: 3000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | −iso4217-usd 13.21 million Calculation and evidence-13206000 − 3000 iso4217-usd Exact free cash flow: -13209000 iso4217-usd
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2014 2014-01-01 – 2014-12-31 | −iso4217-usd 30.71 million Exact valueExact value: -30712000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | −iso4217-usd 26.23 million Exact valueExact value: -26230000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | iso4217-usd 9,000 Exact valueExact value: 9000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | −iso4217-usd 26.24 million Calculation and evidence-26230000 − 9000 iso4217-usd Exact free cash flow: -26239000 iso4217-usd
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2015 2015-01-01 – 2015-12-31 | −iso4217-usd 14.2 million Exact valueExact value: -14197000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | −iso4217-usd 14.36 million Exact valueExact value: -14357000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2016 2016-01-01 – 2016-12-31 | −iso4217-usd 11.16 million Exact valueExact value: -11164000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | −iso4217-usd 10.33 million Exact valueExact value: -10329000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | −iso4217-usd 8.63 million Exact valueExact value: -8628000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | −iso4217-usd 9.97 million Exact valueExact value: -9968000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | iso4217-usd 3,000 Exact valueExact value: 3000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | −iso4217-usd 9.97 million Calculation and evidence-9968000 − 3000 iso4217-usd Exact free cash flow: -9971000 iso4217-usd
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | −iso4217-usd 6.78 million Exact valueExact value: -6778000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | −iso4217-usd 13.46 million Exact valueExact value: -13457000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | iso4217-usd 4,000 Exact valueExact value: 4000 iso4217-usd Share or citeThe citation records this snapshot. The page link may show a newer release later. | −iso4217-usd 13.46 million Calculation and evidence-13457000 − 4000 iso4217-usd Exact free cash flow: -13461000 iso4217-usd
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
30 filings · 1,753 latest values · 1,753 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001563855, 1563855, SPHS, edgar:1563855, sphs
Also known as SOPHIRIS BIO INC.